Posted by ABMN Staff on Mar 28th, 2024
HC Wainwright reaffirmed their buy rating on shares of Vigil Neuroscience (NASDAQ:VIGL – Free Report) in a research note released on Wednesday, Benzinga reports. HC Wainwright currently has a $24.00 price target on the stock.
Separately,...
More of this article »